The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
Open accessAbstract
BACKGROUND The optimum systolic blood pressure after endovascular thrombectomy for acute ischaemic stroke is uncertain. We aimed to compare the safety and efficacy of blood pressure lowering treatment according to more intensive versus less intensive treatment targets in patients with elevated blood pressure after reperfusion with endovascular treatment. METHODS We conducted an open-label, blinded-endpoint, randomised controlled trial at 44 tertiary-level hospitals in China. Eligible patients (aged ≥18 years) had persistently elevated systolic blood pressure (≥140 mm Hg for >10 min) following successful reperfusion with endovascular thrombectomy for acute ischaemic stroke from any intracranial large-vessel occlusion. Patients were randomly assigned (1:1, by a central, web-based program with a minimisation algorithm) to more intensive treatment (systolic blood pressure target <120 mm Hg) or less intensive treatment (target 140-180 mm Hg) to be achieved within 1 h and sustained for 72 h. The primary efficacy outcome was functional recovery, assessed according to the distribution in scores on the modified Rankin scale (range 0 [no symptoms] to 6 [death]) at 90 days. Analyses were done according to the modified intention-to-treat principle. Efficacy analyses were performed with proportional odds logistic regression with adjustment for treatment allocation as a fixed effect, site as a random effect, and baseline prognostic factors, and included all randomly assigned patients who provided consent and had available data for the primary outcome. The safety analysis included all randomly assigned patients. The treatment effects were expressed as odds ratios (ORs). This trial is registered at ClinicalTrials.gov, NCT04140110, and the Chinese Clinical Trial Registry, 1900027785; recruitment has stopped at all participating centres. FINDINGS Between July 20, 2020, and March 7, 2022, 821 patients were randomly assigned. The trial was stopped after review of the outcome data on June 22, 2022, due to persistent efficacy and safety concerns. 407 participants were assigned to the more intensive treatment group and 409 to the less intensive treatment group, of whom 404 patients in the more intensive treatment group and 406 patients in the less intensive treatment group had primary outcome data available. The likelihood of poor functional outcome was greater in the more intensive treatment group than the less intensive treatment group (common OR 1·37 [95% CI 1·07-1·76]). Compared with the less intensive treatment group, the more intensive treatment group had more early neurological deterioration (common OR 1·53 [95% 1·18-1·97]) and major disability at 90 days (OR 2·07 [95% CI 1·47-2·93]) but there were no significant differences in symptomatic intracerebral haemorrhage. There were no significant differences in serious adverse events or mortality between groups. INTERPRETATION Intensive control of systolic blood pressure to lower than 120 mm Hg should be avoided to prevent compromising the functional recovery of patients who have received endovascular thrombectomy for acute ischaemic stroke due to intracranial large-vessel occlusion. FUNDING The Shanghai Hospital Development Center; National Health and Medical Research Council of Australia; Medical Research Futures Fund of Australia; China Stroke Prevention; Shanghai Changhai Hospital, Science and Technology Commission of Shanghai Municipality; Takeda China; Hasten Biopharmaceutic; Genesis Medtech; Penumbra.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Self-citationEncyclopedia of research design
(2011) · Choice Reviews Online · doi:10.5860/choice.48-2447 · Cited by 1,910
von Kummer, R., Broderick, J. P., Campbell, B. C. V., Demchuk, A., Goyal, M., Hill, M. D., Treurniet, K. M., Majoie, C. B. L. M., Marquering, H. A., Mazya, M. V., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010049 · Cited by 1,409
Self-citationDo Clinicians Overestimate the Severity of Intracerebral Hemorrhage?
Tilling, E. J., El Tawil, S., & Muir, K. W. (2019) · Stroke · doi:10.1161/strokeaha.118.022606 · Cited by 1,120
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
Yang, P., Zhang, Y., Zhang, L., Zhang, Y., Treurniet, K. M., Chen, W., Peng, Y., Han, H., Wang, J., Wang, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001123 · Cited by 829
Self-citationZi, W., Qiu, Z., Li, F., Sang, H., Wu, D., Luo, W., Liu, S., Yuan, J., Song, J., Shi, Z., et al. (2021) · JAMA · doi:10.1001/jama.2020.23523 · Cited by 529
Self-citationWarach, S., & Latour, L. L. (2004) · Stroke · doi:10.1161/01.str.0000144051.32131.09 · Cited by 410
Renú, A., Millán, M., San Román, L., Blasco, J., Martí-Fàbregas, J., Terceño, M., Amaro, S., Serena, J., Urra, X., Laredo, C., et al. (2022) · JAMA · doi:10.1001/jama.2022.1645 · Cited by 380
Anderson, C. S., Huang, Y., Lindley, R. I., Chen, X., Arima, H., Chen, G., Li, Q., Billot, L., Delcourt, C., Bath, P. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30038-8 · Cited by 278
Self-citationMazighi, M., Richard, S., Lapergue, B., Sibon, I., Gory, B., Berge, J., Consoli, A., Labreuche, J., Olivot, J.-M., Broderick, J., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30483-x · Cited by 237
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Self-citationHilkens, N. A., Casolla, B., Leung, T. W., & de Leeuw, F.-E. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00642-1 · Cited by 681
Metadata
- Authors
- Yang, P., Song, L., Zhang, Y., Zhang, X., Chen, X., Li, Y., Sun, L., Wan, Y., Billot, L., Li, Q., Ren, X., Shen, H., Zhang, L., Li, Z., Xing, P., Zhang, Y., Zhang, P., Hua, W., Shen, F., Zhou, Y., Tian, B., Chen, W., Han, H., Zhang, L., Xu, C., Li, T., Peng, Y., Yue, X., Chen, S., Wen, C., Wan, S., Yin, C., Wei, M., Shu, H., Nan, G., Liu, S., Liu, W., Cai, Y., Sui, Y., Chen, M., Zhou, Y., Zuo, Q., Dai, D., Zhao, R., Li, Q., Huang, Q., Xu, Y., Deng, B., Wu, T., Lu, J., Wang, X., Parsons, M. W., Butcher, K., Campbell, B., Robinson, T. G., Goyal, M., Dippel, D., Roos, Y., Majoie, C., Wang, L., Wang, Y., Liu, J., & Anderson, C. S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 400
- Issue
- 10363
- Pages
- 1585-1596
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4307728974
- Cited by
- 264
- References
- 26
- FWCI
- 30.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(22)01882-7
- The paper
- Yang, P., Song, L., Zhang, Y., Zhang, X., Chen, X., Li, Y., Sun, L., Wan, Y., Billot, L., Li, Q., Ren, X., Shen, H., Zhang, L., Li, Z., Xing, P., Zhang, Y., Zhang, P., Hua, W., Shen, F., . . . Anderson, C. S. (2022). Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(22)01882-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.